Apr 24 |
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Apr 9 |
Q4 2023 Cue Biopharma Inc Earnings Call
|
Apr 9 |
Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...
|
Apr 9 |
Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call Transcript
|
Apr 8 |
Cue Biopharma GAAP EPS of -$0.28 misses by $0.01
|
Apr 8 |
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
|
Apr 2 |
Cue Biopharma to Host Business Update Call and Webcast
|
Mar 13 |
Jefferies starts Cue at buy, cites partnering potential
|
Feb 29 |
Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
|
Feb 27 |
Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?
|